Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Guardant Health (GH)
NASDAQ:GH
Guardant Health (GH) Stock Price & Analysis
1,514 Followers
GH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$24.63 - $78.34
Previous Close$31.48
Volume1.00M
Average Volume (3M)1.62M
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$958.04M
Total Debt (Recent Filing)$1.37B
Price to Earnings (P/E)-5.3
Beta1.06
Next EarningsFeb 22, 2023
EPS Estimate-$1.39
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$65.57
EPS (TTM)-5.93
Shares Outstanding102,436,169
R-Squared0.07
Standard Deviation0.17
10 Day Avg. Volume1,855,870
30 Day Avg. Volume1,621,761
Price to Book (P/B)21.48
Price to Sales (P/S)10.06
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-11.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside108.32% Upside
Rating ConsensusStrong Buy
Alpha0.00419
Number of Analyst Covering14
Guardant Health News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GH FAQ
What was Guardant Health’s price range in the past 12 months?
Guardant Health lowest stock price was $24.63 and its highest was $78.34 in the past 12 months.
What is Guardant Health’s market cap?
Currently, no data Available
When is Guardant Health’s upcoming earnings report date?
Guardant Health’s upcoming earnings report date is Feb 22, 2023 which is in 25 days.
How were Guardant Health’s earnings last quarter?
Guardant Health released its earnings results on Nov 03, 2022. The company reported -$1.58 earnings per share for the quarter, missing the consensus estimate of -$1.281 by -$0.299.
Is Guardant Health overvalued?
According to Wall Street analysts Guardant Health’s price is currently Undervalued.
Does Guardant Health pay dividends?
Guardant Health does not currently pay dividends.
What is Guardant Health’s EPS estimate?
Guardant Health’s EPS estimate is -$1.39.
How many shares outstanding does Guardant Health have?
Guardant Health has 102,436,170 shares outstanding.
What happened to Guardant Health’s price movement after its last earnings report?
Guardant Health reported an EPS of -$1.58 in its last earnings report, missing expectations of -$1.281. Following the earnings report the stock price went up 4.928%.
Which hedge fund is a major shareholder of Guardant Health?
Among the largest hedge funds holding Guardant Health’s share is Viking Global Investors LP. It holds Guardant Health’s shares valued at 206M.
---
Guardant Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$65.57
$65.57
Blogger Sentiment
Neutral
GH Sentiment 50%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 1.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $162.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▲ 0.7%
Last 30 Days ▼ 1.8%
Last 30 Days ▼ 1.8%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-48.89%
12-Months-Change
Fundamentals
Return on Equity
-138.23%
Trailing 12-Months
Asset Growth
-23.53%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Guardant Health
Guardant Health, Inc. is a precision oncology company, which engages in provision of precision oncology testing and development services. It focuses performing blood tests, vast data sets, and advanced analytics to conquer cancer. The company was founded by Helmy Eltoukhy and AmirAli H. Talasaz in 2012 and is headquartered in Redwood City, CA.
---
---